Proteomics identifies multipotent and low oncogenic risk stem cells of the spleen

International Journal of Biochemistry and Cell Biology

Volumn 42, Issue 10, 2010, Pages 1651-1660

  Dieguez Acuña, Francisco ^a,b   Kodama, Shohta ^b,c   Okubo, Yoshiaki ^b   Paz, Ana Cristina ^c   Gygi, Steven P ^a   Faustman, Denise L ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Cancer stem cells; Hox11; Mass spectrometry; Multipotency; Proteomics; Regeneration; Spleen; Stem cells

Indexed keywords

CD45 ANTIGEN; MESSENGER RNA; OCTAMER TRANSCRIPTION FACTOR 4; PROTEOME; TRANSCRIPTION FACTOR GLI3; TRANSCRIPTION FACTOR SOX2; WNT2 PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER RISK; DNA REPLICATION; EMBRYONIC STEM CELL; MOUSE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; SPLEEN;

ANIMALS; ANTIGENS, CD45; BIOLOGICAL MARKERS; CELL TRANSFORMATION, NEOPLASTIC; EMBRYONIC STEM CELLS; HOMEODOMAIN PROTEINS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MASS SPECTROMETRY; MICE; MICE, INBRED C57BL; PROTEOMICS; PROTO-ONCOGENE PROTEINS; RISK; SPLEEN; STEM CELL NICHE;

ANIMALIA; IPS; MUS;

EID: 77956183488     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2009.12.001     Document Type: Article

References (58)

1. Anastasi E., Campese A.F., Bellavia D., Bulotta A., Balestri A., Pascucci M., et al. Expression of activated Notch3 in transgenic mice enhances generation of T regulatory cells and protects against experimental autoimmune diabetes. J Immunol 2003, 171:4504-4511.
2. Aoi T., Yae K., Nakagawa M., Ichisaka T., Okita K., Takahashi K., et al. Generation of pluripotent stem cells from adult mouse liver and stomach cells. Science 2008, 321:699-702.
3. Bannerman R.M., Keusch G., Kreimer-Birnbaum M., Vance V.K., Vaughan S. Thalassemia intermedia, with iron overload, cardiac failure, diabetes mellitus, hypopituitarism and porphyrinuria. Am J Med 1967, 42:476-486.
4. Blank U., Karlsson G., Karlsson S. Signalling pathways governing stem-cell fate. Blood 2008, 111:492-503.
5. Chang C.W., Lai Y.S., Pawlik K.M., Liu K., Sun C.W., Li C., et al. Polycistronic lentiviral vector for " hit and run" reprogramming of adult skin fibroblasts to induced pluripotent stem cells. Stem Cells 2009, 27:1042-1049.
6. Chen G., Wang H., Gharib T.G., Huang C.C., Thomas D.G., Shedden K.A., et al. Overexpression of oncoprotein 18 correlates with poor differentiation in lung adenocarcinomas. Mol Cell Proteomics 2003, 2:107-116.
7. Christiansen J.H., Dennis C.L., Wicking C.A., Monkley S.J., Wilkinson D.G., Wainwright B.J. Murine Wnt-11 and Wnt-12 have temporally and spatially restricted expression patterns during embryonic development. Mech Dev 1995, 51:341-350.
8. Cumano A., Ferraz J.C., Klaine M., Di Santo J.P., Godin I. Intraembryonic, but not yolk sac hematopoietic precursors, isolated before circulation, provide long-term multilineage reconstitution. Immunity 2001, 15:477-485.
9. Dalerba P., Cho R.W., Clarke M.F. Cancer stem cells: models and concepts. Annu Rev Med 2007, 58:267-284.
10. Dear T.N., Colledge W.H., Carlton M.B., Lavenir I., Larson T., Smith A.J., et al. The Hox11 gene is essential for cell survival during spleen development. Development 1995, 121:2909-2915.
11. Dieguez-Acuna F.J., Gerber S.A., Kodama S., Elias J.E., Beausoleil S.A., Faustman D., et al. Characterization of mouse spleen cells by subtractive proteomics. Mol Cell Proteomics 2005, 4:1459-1470.
12. Dieguez-Acuna F.J., Gygi S.P., Davis M., Faustman D.L. Splenectomy: a new treatment option for ALL tumors expressing Hox-11 and a means to test the stem cell hypothesis of cancer in humans. Leukemia 2007, 21:2192-2194.
13. Duncan A.W., Rattis F.M., DiMascio L.N., Congdon K.L., Pazianos G., Zhao C., et al. Integration of Notch and Wnt signaling in hematopoietic stem cell maintenance. Nat Immunol 2005, 6:314-322.
14. Etheridge S.L., Spencer G.J., Heath D.J., Genever P.G. Expression profiling and functional analysis of Wnt signaling mechanisms in mesenchymal stem cells. Stem Cells 2004, 22:849-860.
15. Ferrando A.A., Neuberg D.S., Staunton J., Loh M.L., Huard C., Raimondi S.C., et al. Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. Cancer Cell 2002, 1:75-87.
16. Gavin B.J., McMahon J.A., McMahon A.P. Expression of multiple novel Wnt-1/int-1-related genes during fetal and adult mouse development. Genes Dev 1990, 4:2319-2332.
17. Govil S., Imrie C.W. Value of splenic preservation during distal pancreatectomy for chronic pancreatitis. Br J Surg 1999, 86:895-898.
18. Hutchins R.R., Hart R.S., Pacifico M., Bradley N.J., Williamson R.C. Long-term results of distal pancreatectomy for chronic pancreatitis in 90 patients. Ann Surg 2002, 236:612-618.
19. Jia T., Pamer E.G. Immunology. Dispensable but not irrelevant. Science 2009, 325:549-550.
20. Karumbayaram S., Novitch B.G., Patterson M., Umbach J.A., Richter L., Lindgren A., et al. Directed differentiation of human-induced pluripotent stem cells generates active motor neurons. Stem Cells 2009, 27:806-811.
21. Kawahira H., Scheel D.W., Smith S.B., German M.S., Hebrok M. Hedgehog signaling regulates expansion of pancreatic epithelial cells. Dev Biol 2005, 280:111-121.
22. Khaldoyanidi S., Sikora L., Broide D.H., Rothenberg M.E., Sriramarao P. Constitutive overexpression of IL-5 induces extramedullary hematopoiesis in the spleen. Blood 2003, 101:863-868.
23. Kim J.B., Zaehres H., Wu G., Gentile L., Ko K., Sebastiano V., et al. Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors. Nature 2008, 454:646-650.
24. Kodama S., Davis M., Faustman D.L. Diabetes and stem cell researchers turn to the lowly spleen. Sci Aging Knowledge Environ 2005, 2005:pe2.
25. Kodama S., Davis M., Faustman D.L. Regenerative medicine: a radical reappraisal of the spleen. Trends Mol Med 2005, 11:271-276.
26. Kodama S., Kuhtreiber W., Fujimura S., Dale E.A., Faustman D.L. Islet regeneration during the reversal of autoimmune diabetes in NOD mice. Science 2003, 302:1223-1227.
27. Koziel L., Wuelling M., Schneider S., Vortkamp A. Gli3 acts as a repressor downstream of Ihh in regulating two distinct steps of chondrocyte differentiation. Development 2005, 132:5249-5260.
28. Lee B.W., Tan S.H., Lee W.K., Yap H.K., Aw S.E., Wong H.B. Glucose tolerance test and insulin levels in children with transfusion-dependent thalassaemia. Ann Trop Paediatr 1985, 5:215-218.
29. Li Y., Zhang H., Choi S.C., Litingtung Y., Chiang C. Sonic hedgehog signaling regulates Gli3 processing, mesenchymal proliferation, and differentiation during mouse lung organogenesis. Dev Biol 2004, 270:214-231.
30. Lonyai A., Kodama S., Burger D., Davis M., Faustman D.L. The promise of Hox11+ stem cells of the spleen for treating autoimmune diseases. Horm Metab Res 2008, 40:137-146.
31. Macias M.P., Fitzpatrick L.A., Brenneise I., McGarry M.P., Lee J.J., Lee N.A. Expression of IL-5 alters bone metabolism and induces ossification of the spleen in transgenic mice. J Clin Invest 2001, 107:949-959.
32. Maloof J.N., Whangbo J., Harris J.M., Jongeward G.D., Kenyon C. A Wnt signaling pathway controls hox gene expression and neuroblast migration in C. elegans. Development 1999, 126:37-49.
33. Matsubara J., Nishina T., Yamada Y., Moriwaki T., Shimoda T., Kajiwara T., et al. Impacts of excision repair cross-complementing gene 1 (ERCC1), dihydropyrimidine dehydrogenase, and epidermal growth factor receptor on the outcomes of patients with advanced gastric cancer. Br J Cancer 2008, 98:832-839.
34. Medvinsky A., Dzierzak E. Definitive hematopoiesis is autonomously initiated by the AGM region. Cell 1996, 86:897-906.
35. Medvinsky A.L., Samoylina N.L., Muller A.M., Dzierzak E.A. An early pre-liver intraembryonic source of CFU-S in the developing mouse. Nature 1993, 364:64-67.
36. Mo R., Freer A.M., Zinyk D.L., Crackower M.A., Michaud J., Heng H.H., et al. Specific and redundant functions of Gli2 and Gli3 zinc finger genes in skeletal patterning and development. Development 1997, 124:113-123.
37. Okita K., Ichisaka T., Yamanaka S. Generation of germline-competent induced pluripotent stem cells. Nature 2007, 448:313-317.
38. Okita K., Nakagawa M., Hyenjong H., Ichisaka T., Yamanaka S. Generation of mouse induced pluripotent stem cells without viral vectors. Science 2008, 322:949-953.
39. Park I.H., Zhao R., West J.A., Yabuuchi A., Huo H., Ince T.A., et al. Reprogramming of human somatic cells to pluripotency with defined factors. Nature 2008, 451:141-146.
40. Park S., Hong S.M., Ahn I.S. Can splenocytes enhance pancreatic beta-cell function and mass in 90% pancreatectomized rats fed a high fat diet?. Life Sci 2009, 84:358-363.
41. Parr B.A., Shea M.J., Vassileva G., McMahon A.P. Mouse Wnt genes exhibit discrete domains of expression in the early embryonic CNS and limb buds. Development 1993, 119:247-261.
42. Peng J., Elias J.E., Thoreen C.C., Licklider L.J., Gygi S.P. Evaluation of multidimensional chromatography coupled with tandem mass spectrometry (LC/LC-MS/MS) for large-scale protein analysis: the yeast proteome. J Proteome Res 2003, 2:43-50.
43. Raju K., Tang S., Dube I.D., Kamel-Reid S., Bryce D.M., Breitman M.L. Characterization and developmental expression of Tlx-1, the murine homolog of HOX11. Mech Dev 1993, 44:51-64.
44. Reya T., Cleavers H. Wnt signalling in stem cells and cancer. Nature 2005, 434:843-850.
45. Riz I., Hawley R.G. G1/S transcriptional networks modulated by the HOX11/TLX1 oncogene of T-cell acute lymphoblastic leukemia. Oncogene 2005, 24:5561-5575.
46. Roberts C.W., Shutter J.R., Korsmeyer S.J. Hox11 controls the genesis of the spleen. Nature 1994, 368:747-749.
47. Robertson S.A., Rowan-Hull A.M., Johnson P.R. The spleen-a potential source of new islets for transplantation?. J Pediatr Surg 2008, 43:274-278.
48. Robinette C.D., Fraumeni J.F. Splenectomy and subsequent mortality in veterans of the 1939-45 war. Lancet 1977, 2:127-129.
49. Senju S., Haruta M., Matsunaga Y., Fukushima S., Ikeda T., Takahashi K., et al. Characterization of dendritic cells and macrophages generated by directed differentiation from mouse induced pluripotent stem cells. Stem Cells 2009, 27:1021-1031.
50. Swirski F.K., Nahrendorf M., Etzrodt M., Wildgruber M., Cortez-Retamozo V., Panizzi P., et al. Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science 2009, 325:612-616.
51. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676.
52. Theil T. Gli3 is required for the specification and differentiation of preplate neurons. Dev Biol 2005, 286:559-571.
53. Tran S.D., Kodama S., Lodde B.M., Szalayova I., Key S., Khalili S., et al. Reversal of Sjogren's-like syndrome in non-obese diabetic mice. Ann Rheum Dis 2007, 66:812-814.
54. Willert K., Brown J.D., Danenberg E., Duncan A.W., Weissman I.L., Reya T., et al. Wnt proteins are lipid-modified and can act as stem cell growth factors. Nature 2003, 423:448-452.
55. Wilson A., Radtke F. Multiple functions of Notch signaling in self-renewing organs and cancer. FEBS Lett 2006, 580:2860-2868.
56. Yates J.R., Eng J.K., McCormack A.L., Schieltz D. Method to correlate tandem mass spectra of modified peptides to amino acid sequences in the protein database. Anal Chem 1995, 67:1426-1436.
57. Yin D., Tao J., Lee D.D., Shen J., Hara M., Lopez J., et al. Recovery of islet beta-cell function in streptozotocin-induced diabetic mice: an indirect role for the spleen. Diabetes 2006, 55:3256-3263.
58. Zeeberg B., Feng W., Wang G., Wang M., Fojo A., Sunshine M., et al. GoMiner: a resource for biological interpretation of genomic and proteomic data. Genome Biol 2003, 4:R28.